innovatis AG Bielefeld and Bayer Technology Services Leverkusen conclude strategic alliance
Online analysis for the biopharmaceutical industry
In forming this partnership, the companies are responding to global efforts to automate analytical processes. BaychroMAT® system solutions provide the basis for optimizing manufacturing processes for biopharmaceutical drugs. When it comes to quality and reproducibility, the fully automatic process control provided by BaychroMAT® system solutions is essential for implementing the operational excellence concept in biopharmaceutical processes.
“This process analysis bioplatform makes our two companies the world’s only manufacturers to have produced an all-in-one solution of this kind,” says Michael Grohmann, member of the Management Board of innovatis AG.
The cooperation agreement between innovatis and BTS was concluded to support the pharmaceutical industry, implement process analysis projects and thus meet the demand for “Quality by Design” in production and process development urged by the US-Food & Drug Administration (FDA) in the Process Analyzer Technology initiative. Both companies will see them adding further components to the BaychroMAT® bioplatform.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.